Clinical Trial

Increasing Resiliency Among Early Post-Treatment Lymphoma Survivors

Name: Increasing Resiliency Among Early Post-Treatment Lymphoma Survivors — clinical trial record (NCT07014293)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting

View on ClinicalTrials.gov →

Summary

The goal of this clinical trial is to learn if a mind body resilience group program can help increase lymphoma survivors' ability to cope with and manage the challenges that come with the transition into early post treatment survivorship.

Protocol Amendment History 1 change

critical Recruitment opened 2026-07-07

Trial Details

NCT Number	NCT07014293
Lead Sponsor	Massachusetts General Hospital
Conditions	Lymphoma
Enrollment	254 participants
Start Date	2026-08-31
Primary Completion	2030-07-01 (estimated)
Study Completion	2030-07-01 (estimated)
Updated on ClinicalTrials.gov	2026-08-11